![]() Tizona Therapeutics Tizona Therapeutics is harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. | ![]() Twentyeight-Seven Therapeutics Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of non-coding RNA (ncRNA) function to treat cancer and other human diseases. | ![]() Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. | |||
Founding Date | Founding Date 2014 | Founding Date 2014 | Founding Date 2016 | Founding Date 2013 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Cambourne, GB HQ | Locations South San Francisco, US HQ | Locations Watertown, US HQ | Locations San Diego, US HQ | Locations Berkeley, US HQ |
Employees | Employees 24 | Employees 24 | Employees 6 | Employees 22 | Employees 11 |
Funding | |||||
Latest funding round | Latest funding round $ 15.9m (over 4 years ago) | Latest funding round $ 43m (about 10 years ago) | Latest funding round $ 15m (about 7 years ago) | Latest funding round $ 1.9m (over 6 years ago) | Latest funding round $ 34m (about 6 years ago) |
Total funding raised | Total funding raised $ 15.9m | Total funding raised $ 70m | Total funding raised $ 80m | Total funding raised $ 21.9m | Total funding raised $ 34m |

Tizona Therapeutics is harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.
View company
Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of non-coding RNA (ncRNA) function to treat cancer and other human diseases.
View company
Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.
View company
Actym Therapeutics is a preclinical immuno-oncology company.
View company